Gynecomastia is a condition in which the male breast is enlarged due to a hormone imbalance. It may be due to the blocking of testosterone or the increase in estrogen levels. Several health conditions may cause the development of gynecomastia, according to the Mayo Clinic. They are:
- Starvation/malnutrition – Levels of testosterone drop when the body does not get ample nutrition, while estrogen levels remain the same.
- Hyperthyroidism — A condition in which the thyroid gland produces excessive thyroxine, throwing the body’s hormones into imbalance.
- Hypogonadism – A condition that interrupts regular testosterone production.
- Liver failure/cirrhosis
- Tumors – Particularly those involving the testes, as they may impact the production of hormones.
- Kidney failure – Hormonal imbalances are a common aspect of regular hemodialysis.
- Aging – Hormonal changes are common results of aging, especially in overweight males.
Another cause of gynecomastia is the use of the antipsychotic drug Risperdal. The effects of this prescription medication have affected many men over the years, causing the physical condition that often leads to physical discomfort and embarrassment. If you have suffered as a result of the drug Risperdal, speak with our lawyers at Williams Hart today by calling our office at (800) 220-9341.
Non-cancerous, smooth muscle tumors that develop on the walls of the uterus are called uterine fibroids. Generally, uterine fibroids are harmless and are not associated with the risk of uterine cancer; however, there are cases where the use of a power morcellator in surgery spreads the fibroids throughout the body and creates the risk that these cells will metastasize into a rare cancer called leiomyosarcoma.
Here are the symptoms of uterine fibroids, according to Mayo Clinic:
- Long menstrual periods (seven days or more)
- Heavy menstruation
- Pain and pressure on the pelvis
- Frequent urination
- Difficulty with urination or emptying the bladder
- Painful sensation in the back and legs
If you are experiencing these symptoms, you may want to speak to your doctor about whether or not you have uterine fibroids. The sooner you take action, the better your chance of treating the condition before additional complications occur.
If you have been diagnosed with leiomyosarcoma and you think it was caused by the controversial medical device known as a power morcellator, speak with our lawyers at Williams Hart today by calling our office at (800) 220-9341.
Kentucky New Era reported that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, agreed to a $15.5 million settlement on December 22. The case was a consumer protection lawsuit in Kentucky that accused Johnson & Johnson of falsely marketing the second-generation antipsychotic prescription drug Risperdal.
The Kentucky Consumer Protection lawsuit stated that the manufacturer of the antipsychotic drug did not inform consumers of its dangers and that the drug was marketed for purposes other than those ordered by the U.S. Food and Drug Administration. Attorney General Conway said, “Janssen and Johnson & Johnson put patients at risk when they marketed Risperdal without disclosing the drug’s known side effects.”
According to reports, Janssen is not allowed to promote Risperdal for purposes not approved by the FDA or for populations in which it is not approved. Kentucky required Janssen to openly discuss the risks of the drug in advertisements.
Risperdal spawned male breast growth lawsuits all over the country, and there are still many cases on trial. If you have suffered any adverse side effects while taking Risperdal, contact our lawyers at Williams Hart by calling (800) 220-9341 today to learn how we can help you.
In early 2014, an announcement by the U.S. Food and Drug Administration shocked medical communities after power morcellators were said to be a threat when used in certain surgeries. A power morcellator is an electric-powered medical device used to break down large tissues into smaller fragments so that they may be removed through small incisions. It is commonly used in the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy).
After many years of research, the FDA found that morcellators could spread concealed cancerous tissues to different parts of the body. There have been lawsuits in which women have developed leiomyosarcoma after the use of power morcellators in surgical procedures. The lawsuits also accuse manufacturers and medical professionals of not disclosing the side effects of the product.
If you have been affected by the use of power morcellator, please bring your case to our esteemed lawyers at Williams Hart for help in pursuing compensation for negligent pharmaceutical manufacturers. Call us now at (800) 220-9341.
According to the Sarcoma Foundation of America (SFA), uterine leiomyosarcoma (LMS) is a type of rare tumor, and only about six women out of a million are diagnosed in the United States every year. Most uterine LMS are diagnosed after a hysterectomy or myomectomy. While it is almost impossible to diagnose LMS before a surgery, an MRI paired with a blood test for serum lactic dehydrogenase (LDH) may result in an accurate diagnosis.
Uterine LMS is treated with surgery, and, according to statistics from the SFA, this treatment prevents the tumor from spreading beyond the uterus in 75% of the patients. Unfortunately, LMS is aggressive; there is only a 50% chance of survival within 5 years for people whose tumor is only in the uterus.
The use of power morcellators in surgeries allegedly metastasizes cancerous cells that become leiomyosarcoma. If you think you have suffered as a result of a power morcellator, speak with our lawyers at Williams Hart to begin building your product liability case. Call us today at (800) 220-9341.
The enlargement of the glandular tissue of the male breast is called gynecomastia. This condition often occurs as a result of a hormonal imbalance in the body, especially when the male body has more estrogen (female hormone) than androgen (male hormone).
Gynecomastia is commonly associated with other medical problems such as chronic kidney failure, cirrhosis of the liver, and hyperthyroidism. One prominent cause of gynecomastia may be the abuse of drugs and several medications.
The anti-psychotic drug Risperdal, manufactured by Johnson & Johnson, has spawned many lawsuits in which gynecomastia was cited as a side effect. Research has also linked this drug to the condition, and the manufacturer has listed gynecomastia as a side effect on the prescription packaging.
If you have been affected by serious side effects of a drug you should have been able to trust, the legal team at Williams Hart is prepared to represent you as you seek justice and compensation. Call us today at (800) 220-9341 to learn about the services we offer.
In the recent years, power morcellators have cause alarm in the women’s health community due to its alleged side effect of potentially spreading cancerous cells and expediting growth. In a recent blog post, the Wall Street Journal listed five things that are important to know when considering these devices. Among the bullet points are the facts that
- There is no surefire way to detect whether a fibroid is cancerous before surgery
- Morcellators are not perfect — these tools do leave bits of tissue in the body
- While some doctors are beginning to implement the use of bags to help contain the fibroid tissue, many gynecologists do not feel this is necessary
- There are alternative surgeries available to women with fibroids that may also offer smaller incisions and minimally invasive operations
While some doctors feel that there are benefits to the use of this tool, others have made it clear that it could pose dangerous risks to some women. If you have suffered as a result of the use of a power morcellator in your gynecological surgery, call the attorneys at Williams Hart today at (800) 220-9341 to speak to a pharmaceutical product liability attorney and learn more about your legal options.
Johnson & Johnson’s Janssen Pharmaceuticals unit was hit with a $5.6 million verdict by a California jury on October 16 over the death of Leo Liu during the company’s clinical study of Risperdal, a well-known anti-psychotic medication. The victim’s mother, Marion Liu, said that her son participated in Janssen’s human drug trial and that he died when Janssen’s employees did nothing to treat his heart condition during the drug trial.
Due to the jury’s finding that Janssen Research and Development LLC was 70% responsible for Liu’s death in the trial, the Johnson & Johnson subsidiary has been ordered to pay the $5.6 million to Liu’s family. Liu’s psychiatrist, Madeleine Valencerina, was also implemented in the trial. Valencierina allegedly received a payout from Janssen for convincing Liu to join the drug trial; she is being held liable for the remaining 30% of the settlement, bringing the total up to $8 million.
Risperdal is known to cause new or exacerbated conditions in patients who take it for anti-psychosis, and our team of lawyers at Williams Hart want you to know that you may be able to recover compensation for your suffering as a result of this drug. Call us today at (800) 220-9341 to learn more.
The FBI is currently investigating what, exactly, Johnson & Johnson knew about their laparoscopic power morcellator before it was released and while it was on the market, according to a Wall Street Journal article on May 27.
Power morcellators, often used in hysterectomies, are designed to cut up fibroids in the uterus which are then extracted through small incisions. Unfortunately, however, these devices have resulted in the spread of previously undetected uterine cancer in many women. J & J recalled the product last year but has been receiving alerts about its dangers for at least the past nine years.
A former pathologist contacted the company in 2006 to express his concerns that use of the device would spread cancerous cells, thus further threatening a patient’s health. A J & J spokesperson said that after this communication, an additional warning was added to the instructions, explaining that malignant tissue may be spread through its use.
A physician’s assistant in California accumulated a list of women, including her, whose cancers worsened after the device was used in a medical procedure. The list consists of 386 names. This woman, along with the retired pathologists and others who have spoken out against the power morcellator, has been contacted by the FBI as part of its investigation.
The attorneys of Williams Hart are dedicated to representing those whose health has been affected by the use of power morcellators. Call us at (800) 220-9341 today to learn more about holding the responsible parties accountable.
Galactorrhea refers to the spontaneous production of milk in one or both breasts unassociated with breast feeding. Although galactorrhea largely affects women, some cases have been recorded to affect males and children. Galactorrhea is a result of an increased level of prolactin, a hormone responsible for initiating and maintaining milk production in nursing mothers.
Apart from milky discharge in the nipples, galactorrhea may also be accompanied by headaches or problems with vision. Such symptoms may indicate the development of benign growths in the pituitary gland, causing it to produce too much prolactin (prolactinoma). As the benign tumors grow, the pressure inside the skull increases, causing headaches and vision problems.
Risperdal is an atypical anti-psychotic drug well-associated with different adverse effects, including benign growths in the pituitary gland and galactorrhea. To learn more about taking legal action after being hurt by this drug, speak with an attorney at Williams Hart by calling (800) 220-9341 today.